Purpose To this day, there is no cure for recurrent respiratory papillomatosis (RRP). Multiple
surgical procedures are performed to achieve symptom relief and prevention of airway …

Objective Despite recent advancement recurrent respiratory papillomatosis (RRP) remains a
rare but challenging benign airway neoplasm. In recent years there has been significant …

Objective The clinical course of recurrent respiratory papillomatosis (RRP) varies from
spontaneous remission to severe airway obstruction with wide variability in recurrence …

Importance Recurrent respiratory papillomatosis (RRP) is a rare benign chronic disease of
the larynx etiologically linked with the infection of low-risk human papillomavirus (HPV) …

Objectives To characterize treatment response of recurrent respiratory papillomatosis (RRP)
including adult-onset RRP (AORRP) and juvenile-onset RRP (JORRP) to systemic …

Objectives Quality of life studies in recurrent respiratory papillomatosis (RRP) have
traditionally relied upon clinician‐designed survey instruments. This study's objective is to …

Background: Bevacizumab is a vascular endothelial growth factor (VEGF) inhibitor that is
used off-label for select cases of recurrent respiratory papillomatosis (RRP) that are severe …

Introduction: Recurrent respiratory papillomatosis is a rare human papillomavirus (HPV)-
induced condition where warts grow within the airway and especially the larynx to effect …

BACKGROUND Recurrent respiratory papillomatosis (RRP) is a potentially lethal disease
caused by the human papillomavirus (HPV) and characterized by recurrent papillomas in …

Objective To describe iatrogenic laryngeal injury and identify its risk factors in recurrent
respiratory papillomatosis (RRP) patients receiving surgical care. Study Design Case …